Skip to search formSkip to main contentSkip to account menu

mubritinib

Known as: 1-(4-(4-((2-((E)-2-(4-(Trifluoromethyl)phenyl)ethenyl)oxazol-4-yl)methoxy)phenyl)butyl)-1H-1,2,3-triazole 
National Institutes of Health

Related topics

Related topics

2 relations
Receptor Tyrosine Kinase Inhibition

Broader (1)

TAK-165

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The significance of the neuregulin-1/ErbB signaling pathway and its effect on Sox10 expression in the development of terminally differentiated Schwann cells in vitro
Abstract Purpose The purpose of this study was to explore the significance of the neuregulin-1/ErbB signaling pathway and its… 
2019
2019
Mubritinib Shows Activity in Poor Outcome Acute Myeloid Leukemias
A cute myeloid leukemia (AML) is a lethal disease that has a survival rate that leaves only approximately one-fourth of those… 
2018
2018
Abstract 2684: Drug sensitivity profiling of BT-474 breast cancer cell line for identification of novel therapies targeting HER2-positive breast cancer
Developing targeted therapy for breast cancer expressing hormone receptors such as estrogen receptor (ER) and progesterone… 
2016
2016
Abstract 3837: Passenger deletion of ENO1 as a collateral lethality target in cancer
Large scale genomic characterization efforts such as TCGA have painted an unprecedentedly detailed picture of the genetic… 
2012
2012
Ectopic Expression of Mir-125a or Mubritinib Treatment of Human Acute Promyelocytic Leukemia t(15; 17) NB4 Cells Containing Epigenitically Silenced Mir-125a Results in Inhibition of Cell Cycle…
Abstract 2426 Acute Myeloid Leukemia (AML) is defined as rapid growth of abnormal blasts within bone marrow that invade… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)